# Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F

> **NCT04238689** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** TB31F

## Key facts

- **NCT ID:** NCT04238689
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-14
- **Primary completion:** 2021-03-04
- **Final completion:** 2021-03-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04238689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04238689, "Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04238689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*